INS and cancer: This systematic review found that the KD intervention has the potential to benefit cancer-related outcomes such as fat mass, visceral fat mass, LDL cholesterol, total cholesterol, thyroid-stimulating hormone, insulin, blood glucose, β-hydroxybutyrate, emotional function, fatigue, insomnia, social function, and ketosis events in cancer patients.